#600060
Table of Contents
A number sign (#) is used with this entry because of evidence that autosomal recessive nonsyndromic deafness-2 (DFNB2) is caused by homozygous or compound heterozygous mutation in the myosin VIIA gene (MYO7A; 276903) on chromosome 11q13.
Allelic disorders include autosomal dominant deafness-11 (DFNA11; 601317) and Usher syndrome type IB (USH1B; see 276900).
Guilford et al. (1994) reported a consanguineous family from southern Tunisia in which 22 individuals had autosomal recessive nonsyndromic sensorineural deafness. All had profound deafness, and 4 also had vertigo. The age of onset of deafness was variable and reported to range from birth to age 16 years.
Riazuddin et al. (2008) reported a consanguineous Pakistani family in which several members had nonsyndromic sensorineural deafness. None had vestibular or retinal abnormalities.
Hildebrand et al. (2010) reported 3 sibs, born of consanguineous Iranian parents, with autosomal recessive nonsyndromic deafness-2. Onset of hearing loss occurred between ages 7 months and 7 years. Audiologic testing revealed hearing loss at all frequencies, although low frequency hearing was less impaired. All had normal vestibular function, and funduscopic examination and visual acuity tests excluded retinitis pigmentosa in all patients at ages 39, 31, and 42 years, respectively. One patient had a milder phenotype, with later onset and less severe impairment, suggesting the presence of a genetic modifier. The findings confirmed that nonsyndromic hearing loss can be caused by mutation in the MYO7A gene.
Clinical Variability
Zina et al. (2001) reevaluated the family reported by Guilford et al. (1994) and Weil et al. (1997). Since the original reports, 5 patients had developed mild retinal degeneration in addition to the progressive deafness. Fundus examination of 1 patient showed spicule pigmentary changes consistent with retinal dystrophy. Another previously unaffected family member, homozygous for the mutation, had retinitis pigmentosa. Seven patients had abnormal vestibular function as assessed by caloric tests. Zina et al. (2001) concluded that some patients in this Tunisian family had features consistent with Usher syndrome type IB. The findings suggested that other factors must modulate the expression of the phenotype.
By linkage analysis of a consanguineous Tunisian family with autosomal recessive neurosensory deafness, Guilford et al. (1994) found linkage to chromosome 11q13 (maximum lod score of 10.63 at marker D11S527). Homozygosity mapping refined the location of the locus to a 6-cM interval that also contained the olfactory marker protein gene (OMP; 164340). The murine homolog of OMP is tightly linked to the autosomal recessive deafness shaker-1 gene in mice, suggesting that the deafness in this Tunisian family is the human homolog of the mouse shaker-1 mutation.
In affected members of the Tunisian family reported by Guilford et al. (1994), Weil et al. (1997) identified a homozygous mutation in the MYO7A gene (276903.0010).
In affected members of 2 Chinese families with DFNB2, Liu et al. (1997) identified homozygous or compound heterozygous mutations in the MYO7A gene (276903.0007-276903.0009).
In affected members of a consanguineous Pakistani family with DFNB2, Riazuddin et al. (2008) identified a homozygous mutation in the MYO7A gene (276903.0018).
In 3 sibs, born of consanguineous Iranian parents, with DFNB2, Hildebrand et al. (2010) identified a homozygous mutation in the MYO7A gene (R395H; 276903.0021).
Shaker-1 (sh1) homozygous mice show hyperactivity, head-tossing, and circling due to vestibular dysfunction, as well as neuroepithelial-type cochlear defects involving dysfunction and progressive degeneration of the organ of Corti. Gibson et al. (1995) described 3 different mutations in the Myo7a gene that segregated with the disorder in mice. All the mutations were located in the region encoding the myosin head. The sh1 phenotype differs from that of Usher syndrome in humans by the absence of retinal degeneration. Weil et al. (1995) noted that one form of human neurosensory recessive deafness without retinal dystrophy, DFNB2, maps to 11q in the same general region as USH1B and may represent the human equivalent of sh1.
Gibson, F., Walsh, J., Mburu, P., Varela, A., Brown, K. A., Antonio, M., Beisel, K. W., Steel, K. P., Brown, S. D. M. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 374: 62-64, 1995. [PubMed: 7870172, related citations] [Full Text]
Guilford, P., Ayadi, H., Blanchard, S., Chaib, H., Le Paslier, D., Weissenbach, J., Drira, M., Petit, C. A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 gene. Hum. Molec. Genet. 3: 989-993, 1994. [PubMed: 7951250, related citations] [Full Text]
Hildebrand, M. S., Thorne, N. P., Bromhead, C. J., Kahrizi, K., Webster, J. A., Fattahi, Z., Bataejad, M., Kimberling, W. J., Stephan, D., Najmabadi, H., Bahlo, M., Smith, R. J. H. Variable hearing impairment in a DFNB2 family with a novel MYO7A missense mutation. Clin. Genet. 77: 563-571, 2010. [PubMed: 20132242, images, related citations] [Full Text]
Liu, X.-Z., Walsh, J., Mburu, P., Kendrick-Jones, J., Cope, M. J. T. V., Steel, K. P., Brown, S. D. M. Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nature Genet. 16: 188-190, 1997. [PubMed: 9171832, related citations] [Full Text]
Riazuddin, S., Nazli, S., Ahmed, Z. M., Yang, Y., Zulfiqar, F., Shaikh, R. S., Zafar, A. U., Khan, S. N., Sabar, F., Javid, F. T., Wilcox, E. R., Tsilou, E., Boger, E. T., Sellers, J. R., Belyantseva, I. A., Riazuddin, S., Friedman, T. B. Mutation spectrum of MYO7A and evaluation of a novel nonsyndromic deafness DFNB2 allele with residual function. Hum. Mutat. 29: 502-511, 2008. [PubMed: 18181211, related citations] [Full Text]
Weil, D., Blanchard, S., Kaplan, J., Guilford, P., Gibson, F., Walsh, J., Mburu, P., Varela, A., Levilliers, J., Weston, M. D., Kelley, P. M., Kimberling, W. J., Wagenaar, M., Levi-Acobas, F., Larget-Piet, D., Munnich, A., Steel, K. P., Brown, S. D. M., Petit, C. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 374: 60-61, 1995. [PubMed: 7870171, related citations] [Full Text]
Weil, D., Kussel, P., Blanchard, S., Levy, G., Levi-Acobas, F., Drira, M., Ayadi, H., Petit, C. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nature Genet. 16: 191-193, 1997. [PubMed: 9171833, related citations] [Full Text]
Zina, Z., Masmoudi, S., Ayadi, H., Chaker, F., Ghorbel, A. M., Drira, M., Petit, C. From DFNB2 to Usher syndrome: variable expressivity of the same disease. (Letter) Am. J. Med. Genet. 101: 181-183, 2001. [PubMed: 11391666, related citations] [Full Text]
Alternative titles; symbols
ORPHA: 90636; DO: 0110477;
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
11q13.5 | Deafness, autosomal recessive 2 | 600060 | Autosomal recessive | 3 | MYO7A | 276903 |
A number sign (#) is used with this entry because of evidence that autosomal recessive nonsyndromic deafness-2 (DFNB2) is caused by homozygous or compound heterozygous mutation in the myosin VIIA gene (MYO7A; 276903) on chromosome 11q13.
Allelic disorders include autosomal dominant deafness-11 (DFNA11; 601317) and Usher syndrome type IB (USH1B; see 276900).
Guilford et al. (1994) reported a consanguineous family from southern Tunisia in which 22 individuals had autosomal recessive nonsyndromic sensorineural deafness. All had profound deafness, and 4 also had vertigo. The age of onset of deafness was variable and reported to range from birth to age 16 years.
Riazuddin et al. (2008) reported a consanguineous Pakistani family in which several members had nonsyndromic sensorineural deafness. None had vestibular or retinal abnormalities.
Hildebrand et al. (2010) reported 3 sibs, born of consanguineous Iranian parents, with autosomal recessive nonsyndromic deafness-2. Onset of hearing loss occurred between ages 7 months and 7 years. Audiologic testing revealed hearing loss at all frequencies, although low frequency hearing was less impaired. All had normal vestibular function, and funduscopic examination and visual acuity tests excluded retinitis pigmentosa in all patients at ages 39, 31, and 42 years, respectively. One patient had a milder phenotype, with later onset and less severe impairment, suggesting the presence of a genetic modifier. The findings confirmed that nonsyndromic hearing loss can be caused by mutation in the MYO7A gene.
Clinical Variability
Zina et al. (2001) reevaluated the family reported by Guilford et al. (1994) and Weil et al. (1997). Since the original reports, 5 patients had developed mild retinal degeneration in addition to the progressive deafness. Fundus examination of 1 patient showed spicule pigmentary changes consistent with retinal dystrophy. Another previously unaffected family member, homozygous for the mutation, had retinitis pigmentosa. Seven patients had abnormal vestibular function as assessed by caloric tests. Zina et al. (2001) concluded that some patients in this Tunisian family had features consistent with Usher syndrome type IB. The findings suggested that other factors must modulate the expression of the phenotype.
By linkage analysis of a consanguineous Tunisian family with autosomal recessive neurosensory deafness, Guilford et al. (1994) found linkage to chromosome 11q13 (maximum lod score of 10.63 at marker D11S527). Homozygosity mapping refined the location of the locus to a 6-cM interval that also contained the olfactory marker protein gene (OMP; 164340). The murine homolog of OMP is tightly linked to the autosomal recessive deafness shaker-1 gene in mice, suggesting that the deafness in this Tunisian family is the human homolog of the mouse shaker-1 mutation.
In affected members of the Tunisian family reported by Guilford et al. (1994), Weil et al. (1997) identified a homozygous mutation in the MYO7A gene (276903.0010).
In affected members of 2 Chinese families with DFNB2, Liu et al. (1997) identified homozygous or compound heterozygous mutations in the MYO7A gene (276903.0007-276903.0009).
In affected members of a consanguineous Pakistani family with DFNB2, Riazuddin et al. (2008) identified a homozygous mutation in the MYO7A gene (276903.0018).
In 3 sibs, born of consanguineous Iranian parents, with DFNB2, Hildebrand et al. (2010) identified a homozygous mutation in the MYO7A gene (R395H; 276903.0021).
Shaker-1 (sh1) homozygous mice show hyperactivity, head-tossing, and circling due to vestibular dysfunction, as well as neuroepithelial-type cochlear defects involving dysfunction and progressive degeneration of the organ of Corti. Gibson et al. (1995) described 3 different mutations in the Myo7a gene that segregated with the disorder in mice. All the mutations were located in the region encoding the myosin head. The sh1 phenotype differs from that of Usher syndrome in humans by the absence of retinal degeneration. Weil et al. (1995) noted that one form of human neurosensory recessive deafness without retinal dystrophy, DFNB2, maps to 11q in the same general region as USH1B and may represent the human equivalent of sh1.
Gibson, F., Walsh, J., Mburu, P., Varela, A., Brown, K. A., Antonio, M., Beisel, K. W., Steel, K. P., Brown, S. D. M. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 374: 62-64, 1995. [PubMed: 7870172] [Full Text: https://doi.org/10.1038/374062a0]
Guilford, P., Ayadi, H., Blanchard, S., Chaib, H., Le Paslier, D., Weissenbach, J., Drira, M., Petit, C. A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 gene. Hum. Molec. Genet. 3: 989-993, 1994. [PubMed: 7951250] [Full Text: https://doi.org/10.1093/hmg/3.6.989]
Hildebrand, M. S., Thorne, N. P., Bromhead, C. J., Kahrizi, K., Webster, J. A., Fattahi, Z., Bataejad, M., Kimberling, W. J., Stephan, D., Najmabadi, H., Bahlo, M., Smith, R. J. H. Variable hearing impairment in a DFNB2 family with a novel MYO7A missense mutation. Clin. Genet. 77: 563-571, 2010. [PubMed: 20132242] [Full Text: https://doi.org/10.1111/j.1399-0004.2009.01344.x]
Liu, X.-Z., Walsh, J., Mburu, P., Kendrick-Jones, J., Cope, M. J. T. V., Steel, K. P., Brown, S. D. M. Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nature Genet. 16: 188-190, 1997. [PubMed: 9171832] [Full Text: https://doi.org/10.1038/ng0697-188]
Riazuddin, S., Nazli, S., Ahmed, Z. M., Yang, Y., Zulfiqar, F., Shaikh, R. S., Zafar, A. U., Khan, S. N., Sabar, F., Javid, F. T., Wilcox, E. R., Tsilou, E., Boger, E. T., Sellers, J. R., Belyantseva, I. A., Riazuddin, S., Friedman, T. B. Mutation spectrum of MYO7A and evaluation of a novel nonsyndromic deafness DFNB2 allele with residual function. Hum. Mutat. 29: 502-511, 2008. [PubMed: 18181211] [Full Text: https://doi.org/10.1002/humu.20677]
Weil, D., Blanchard, S., Kaplan, J., Guilford, P., Gibson, F., Walsh, J., Mburu, P., Varela, A., Levilliers, J., Weston, M. D., Kelley, P. M., Kimberling, W. J., Wagenaar, M., Levi-Acobas, F., Larget-Piet, D., Munnich, A., Steel, K. P., Brown, S. D. M., Petit, C. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 374: 60-61, 1995. [PubMed: 7870171] [Full Text: https://doi.org/10.1038/374060a0]
Weil, D., Kussel, P., Blanchard, S., Levy, G., Levi-Acobas, F., Drira, M., Ayadi, H., Petit, C. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nature Genet. 16: 191-193, 1997. [PubMed: 9171833] [Full Text: https://doi.org/10.1038/ng0697-191]
Zina, Z., Masmoudi, S., Ayadi, H., Chaker, F., Ghorbel, A. M., Drira, M., Petit, C. From DFNB2 to Usher syndrome: variable expressivity of the same disease. (Letter) Am. J. Med. Genet. 101: 181-183, 2001. [PubMed: 11391666] [Full Text: https://doi.org/10.1002/ajmg.1335]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM